Preceptor tips for navigating generational differences with introductory and advanced pharmacy practice experience students.

Ideally, precepting during introductory and advanced pharmacy practice experiences should be tailored to meet the individualized needs of learners. Understanding generational similarities and differences that exist between both learners and educators will facilitate meaningful interaction and improve learning outcomes. A common pitfall among preceptors is to judge the values of their pharmacy learners based on the stereotypes of the generations.

Practice Transformation Driven through Academic Partnerships.

Evidence-based interventions have been shown to improve the quality of patient care, reduce costs, and improve overall health outcomes; however, adopting new published research and knowledge into practice has historically been slow, and requires an active, systematic approach to engage clinicians and healthcare administrators in the required change. Pharmacists have been identified as important agents of change and can enhance care delivery in primary care settings through evidence-based interventions. Utilizing the Consolidated Framework for Implementation Research (CFIR) we identify, assess, and share barriers and facilitators to program development, as well as growth and expansion efforts across five discrete, university-subsidized, embedded-pharmacy practices in primary care.

British terrorism preemption: Subjectivity and disjuncture in Channel "de-radicalization" interventions.

This article examines Channel "de-radicalization" interventions, which take place on individuals suspected of having the potential to commit terrorist crimes. Situated within critical security studies, the article explores the British Prevent programme by utilizing primary interviews with hard-to-reach Channel mentors and senior Prevent officials. Following the work of anticipatory risk-governance scholarship, this research illuminates the three processes of risk-visibilization (how an individual becomes sufficiently "seen" as harbouring risk that they are offered Channel mentorship), risk-calculation (how practitioners negotiate supposed riskiness), and risk-knowing (how practitioners "know" risks they observe).

Nanopharmaceuticals (part 1): products on the market.

In 2000, the National Institute of Health launched the National Nanotechnology Initiative to support, coordinate, and advance research and development of nanoscale projects. The impact of this new program on health-science related research and development became quickly visible. Broad governmental financial support advanced the start of new, and the deepening of already existing, interdisciplinary research.